Xcout Intel
NOVOGENIA AG
Novogenia AG provides genetic analysis services alongside the contract manufacturing of personalized supplements and cosmetics based on DNA test results. Operating an in-house laboratory and production facilities in Austria, the company serves individual consumers and business partners seeking precision health and wellness products.
Subscribe to see NOVOGENIA AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NOVOGENIA AG at a glance
NOVOGENIA AG is a biotech company headquartered in Germany. Xcout tracks 3 named people at NOVOGENIA AG, including Michael Huttegger (Chief Operating Officer).
NOVOGENIA AG leadership
- Michael HutteggerChief Operating Officer
- Dr. Daniel WallerstorferFounder & CEO
- Matthias ProbstCFO & Co-founder
NOVOGENIA AG competitors
A few of NOVOGENIA AG's closest competitors — see the full list of competitors and alternatives →
SenzaGen provides in vitro skin sensitization testing services and non-animal toxicity testing solutions using its proprietary GARD technology, which combines genomics and machine learning. The company serves industries such as cosmetics, chemicals, and medical devices by offering regulatory-compliant safety testing and advisory services to predict skin sensitization potency without animal testing.
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
Alithea Genomics SA is a life sciences company located in Epalinges, Switzerland, that specializes in high-throughput transcriptomics solutions.
Source BioScience is a UK-based laboratory services company providing genomics, DNA sequencing, molecular diagnostics, and pathology-related testing. It serves pharmaceutical and biotechnology companies, healthcare organizations, research institutions, and other life-science customers.
Cergentis, now part of Solvias, provides genetic characterization and quality control services using its proprietary Targeted Locus Amplification (TLA) technology platform. The company supports pharmaceutical and biotechnology innovators in the development of safe and effective advanced therapies throughout the drug development lifecycle.
Stilla Technologies is a European biotechnology company based in Paris, France, that specializes in multiplex digital PCR. The company accelerates the development of next-generation genetic tests and maintains global distribution partnerships.
Get NOVOGENIA AG's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about NOVOGENIA AG? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on NOVOGENIA AG in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access